CME Group (NASDAQ:CME) Releases Quarterly Earnings Results, Beats Expectations By $0.25 EPS

CME Group (NASDAQ:CME) posted its quarterly earnings data on Wednesday. The financial services provider reported $3.36 earnings per share for the quarter, topping the consensus estimate of $3.11 by $0.25, FiscalAI reports. The company had revenue of $1.88 billion during the quarter, compared to analyst estimates of $1.77 billion. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The company’s revenue was up 14.5% on a year-over-year basis. During the same quarter last year, the business posted $2.80 earnings per share.

Here are the key takeaways from CME Group’s conference call:

• Record volumes and market depth — Q1 average daily volume hit a company high of 36.2 million contracts (up 22% YoY) with simultaneous record volume across all six asset classes and open interest up ~11% YoY (U.S. Treasury OI reached an all-time high).
• Outstanding financial results — Revenue was $1.9 billion (up 14% YoY), adjusted operating margin a company-record 72.8%, and adjusted EPS of $3.36 (up 20% YoY), driven by higher clearing/transaction fees and market data growth.
• Material shareholder returns and disciplined capital use — CME returned $3.2 billion in Q1 (?$2.7B dividends and $536M repurchases) and said repurchases will remain opportunistic, funded in part by OSTRRA proceeds.
• Clearing and tokenization initiatives to boost collateral efficiency — SEC/CFTC approval to expand the FICC cross?margining program to end users (go-live Apr 30), ongoing tokenization work with Google and banks to enable 24/7 cash/token movement, and exploration of a CME stablecoin to increase margin/capital efficiency.
• Product and client expansion drives distribution — New product moves (24/7 crypto trading May 29, Micro Equity Index options to be cash-settled, Dallas cloud testing and ag contracts migrating to cloud), plus Prediction Markets/FanDuel partnership that brought ~150k new accounts and helped market data revenue reach a record $224M (up 15%).

CME Group Trading Down 1.4%

CME stock traded down $4.00 during midday trading on Friday, reaching $281.47. The company’s stock had a trading volume of 511,419 shares, compared to its average volume of 2,293,494. CME Group has a 52 week low of $257.17 and a 52 week high of $329.16. The stock has a market cap of $100.94 billion, a PE ratio of 24.03, a price-to-earnings-growth ratio of 2.91 and a beta of 0.26. The company has a quick ratio of 1.03, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The business’s 50-day simple moving average is $304.87 and its 200-day simple moving average is $285.91.

CME Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, March 26th. Shareholders of record on Tuesday, March 10th were paid a $1.30 dividend. The ex-dividend date of this dividend was Tuesday, March 10th. This is a boost from CME Group’s previous quarterly dividend of $1.25. This represents a $5.20 dividend on an annualized basis and a yield of 1.8%. CME Group’s payout ratio is 46.59%.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the stock. JPMorgan Chase & Co. raised their price target on shares of CME Group from $266.00 to $271.00 and gave the company an “underweight” rating in a report on Thursday, April 16th. UBS Group reissued a “neutral” rating and issued a $310.00 price target on shares of CME Group in a report on Friday, February 6th. Deutsche Bank Aktiengesellschaft lowered their price target on shares of CME Group from $342.00 to $322.00 and set a “buy” rating for the company in a report on Thursday. Rothschild & Co Redburn lowered their price target on shares of CME Group from $347.00 to $340.00 and set a “neutral” rating for the company in a report on Monday, April 13th. Finally, The Goldman Sachs Group reduced their price objective on shares of CME Group from $275.00 to $267.00 and set a “sell” rating on the stock in a research note on Thursday. Two analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, CME Group has an average rating of “Moderate Buy” and an average target price of $306.71.

Insider Activity

In other news, Director Dennis Suskind sold 748 shares of CME Group stock in a transaction on Friday, February 6th. The shares were sold at an average price of $300.00, for a total transaction of $224,400.00. Following the transaction, the director directly owned 2,699 shares of the company’s stock, valued at $809,700. This trade represents a 21.70% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Martin J. Gepsman sold 300 shares of CME Group stock in a transaction on Friday, February 20th. The stock was sold at an average price of $305.90, for a total transaction of $91,770.00. Following the transaction, the director directly owned 24,999 shares in the company, valued at approximately $7,647,194.10. This represents a 1.19% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders sold 8,539 shares of company stock valued at $2,713,821. 0.30% of the stock is owned by company insiders.

Hedge Funds Weigh In On CME Group

A number of hedge funds and other institutional investors have recently made changes to their positions in CME. Elkhorn Partners Limited Partnership bought a new position in shares of CME Group during the fourth quarter worth $27,000. Strive Asset Management LLC acquired a new stake in shares of CME Group during the third quarter worth $32,000. Acumen Wealth Advisors LLC acquired a new stake in shares of CME Group during the fourth quarter worth $33,000. Kemnay Advisory Services Inc. acquired a new stake in shares of CME Group during the fourth quarter worth $39,000. Finally, Uniplan Investment Counsel Inc. raised its holdings in shares of CME Group by 281.6% during the fourth quarter. Uniplan Investment Counsel Inc. now owns 145 shares of the financial services provider’s stock worth $40,000 after acquiring an additional 107 shares during the period. 87.75% of the stock is owned by institutional investors.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Record Q1 revenue and surge in trading volumes: CME reported record Q1 revenue and a big rise in average daily volume, driven by increased hedging and risk-taking activity—this is the primary driver for the stock’s upside today. Article Title
• Positive Sentiment: Morgan Stanley trims target but stays Overweight: Morgan Stanley cut its PT to $353 from $362 but kept an Overweight rating, signaling continued analyst confidence and upside (~23.7% from the referenced price). Article Title
• Positive Sentiment: TD Cowen lowers target but maintains Buy: TD Cowen trimmed its PT to $323 (from $340) but kept a Buy rating, indicating analysts still see material upside despite more conservative forecasts. Article Title
• Neutral Sentiment: Earnings-call detail and full transcripts available: Management’s call and full transcripts provide color on product mix, client behavior, and seasonality—useful for modeling but not new headline catalysts. Article Title
• Negative Sentiment: Some outlets say Q1 sales/metrics missed estimates: Several reports note revenue or sales came in below analyst expectations on a few metrics despite strong volumes—this fuels profit-taking and keeps upside capped. Article Title
• Negative Sentiment: Goldman cuts target to $267 and retains Sell: Goldman Sachs lowered its PT and continues to carry a Sell rating, which adds downward pressure and contributes to mixed analyst chatter. Article Title
• Negative Sentiment: Some analysts warn valuation remains high: Commentary (e.g., Seeking Alpha) points out the stock still looks expensive on forward multiples despite strong top-line momentum—this may limit sustained upside. Article Title

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.